Though the effect on physician reimbursement will vary, ASCO estimates a 4% decrease for medical oncology, a 3.25% decrease for radiation oncology and a 3.6% decrease for gynecologic oncology in 2025.

After reporting the preliminary data during ASCO, PMV said it plans to ... During the annual meeting of the American Society of Clinical Oncology, AstraZeneca and Daiichi Sankyo reported pivotal ...

Kicking off in Chicago on the 31st May, the 2024 American Society of Clinical Oncology’s Annual Meeting - known as ASCO - welcomed more than forty thousand healthcare professionals through its ...

JCO is the primary forum of scientific discourse for the American Society of Clinical Oncology (ASCO). Published three times a month, JCO is the foremost peer-reviewed journal focusing on clinical ...

If you were unable to attend the ASCO Career Fair at the Annual Meeting or attended ... Learn more about Advocate Health. American Oncology Network, LLC (AON) is an alliance of physicians and seasoned ...

Many people with cancer are interested in using cannabis for symptom management, but few talk to their doctor about it. ASCO ...

Nazli Dizman, MD, discussed the current measures for enforcing ASCO’s language of respect guidelines in the renal cell ...

The findings, presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on Sunday 2 June, involved analysing blood samples from the ChemoNEAR sample collection study for ...

A nurse practitioner discusses ASCO’s recommendations of CDK4/6 inhibitors—namely abemaciclib and ribociclib—in certain high-risk breast cancer settings.

Field medical education before launch is linked to greater launch success, improving treatment adoption by up to 50%. New ...

Katherine Van Loon, MD, MPH, has been appointed as the next editor-in-chief of JCO Global Oncology (JCO GO), an American Society of Clinical Oncology (ASCO) journal.

The top stories in non-small cell lung cancer (NSCLC) for 2024 included practice-changing results in EGFR-mutant disease, an ...